BackPrecision Biosciences Overview
Precision Biosciences Inc

Precision Biosciences Target Price

Where could DTIL trade next? Consensus target price: $20.

Get informed when a big investor buys or sells

+ Follow

Share Price

$7.47

Average Target Price

$20.00167.7% upside

1 analysts in the last 4 months

High: $20 | Low: $20

Analyst Recommendations

No recommendations in the last 4 months.

Revenue & Income Forecast

Analysts' Target Prices

DateAnalystPrice TargetCurrent Upside/Downside
2026-06-09Oppenheimer$20167.7% upsideOpen
2026-03-13JefferiesMaury Raycroft$19154.4% upsideOpen
2024-04-01BTIGJustin Zelin$30301.6% upsideOpen
2022-11-10Goldman Sachs$186.6% downsideOpen

Precision Biosciences (DTIL) FAQ

Precision Biosciences (DTIL) currently reports a target price of $20. Use the charts on this page to explore Precision Biosciences's target price history and peer comparisons.

Analysts' average 12-month price target for Precision Biosciences is $20, about 167.7% upside from the current share price of $7.47. That spread summarizes where covering analysts expect the stock could trade over the next year, not a guarantee. Review the individual firm targets on this page — a wide high-to-low range often means opinion is split.

Start with the current target price of $20, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Precision Biosciences, and consider following DTIL for alerts when major investors trade the stock.

Precision Biosciences is classified in the Healthcare sector. On target price, it currently shows $20. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing DTIL with unrelated industries.